Troy Richards, MD
Radiation Oncology · Shreveport, LANPI 1386671584
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 11.5% — the pattern of someone who eats at a lot of different presentations.
Across 108 payments — averaging $26.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$328
- Visionrt, Inc.$260
- Merck$218
- Profound Medical Corp.$205
- Boston Scientific$203
- AstraZeneca$200
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,854100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 16 | $328 |
| Visionrt, Inc. | 1 | $260 |
| Merck | 10 | $218 |
| Profound Medical Corp. | 1 | $205 |
| Boston Scientific | 2 | $203 |
| AstraZeneca | 10 | $200 |
| Novartis | 8 | $189 |
| Jazz Pharmaceuticals Inc. | 5 | $135 |
| Teleflex LLC | 1 | $107 |
| Johnson & Johnson | 6 | $107 |
| Genentech USA, Inc. | 5 | $95 |
| Regeneron Healthcare Solutions, Inc. | 4 | $77 |
| Astellas Pharma US Inc | 4 | $76 |
| Dendreon Pharmaceuticals LLC | 3 | $73 |
| AbbVie | 3 | $65 |
| Stemline Therapeutics Inc. | 3 | $60 |
| Bayer | 3 | $51 |
| Karyopharm Therapeutics Inc. | 3 | $49 |
| Eisai Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Seagen Inc. | 2 | $33 |
| Incyte Corporation | 2 | $33 |
| Blueprint Medicines Corporation | 1 | $25 |
| Medtronic | 1 | $21 |
| AVEO Pharmaceuticals, Inc. | 1 | $21 |
| Tempus AI, Inc | 1 | $20 |
| Beone Medicines USA, Inc. | 1 | $20 |
| Insulet Corporation | 1 | $19 |
| Acrotech Biopharma Inc. | 1 | $17 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| EMD Serono, Inc. | 1 | $14 |
| Novo Nordisk | 1 | $14 |
| Genmab U.S., Inc. | 1 | $13 |
| Mirati Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tulsa-Pro$205
- Barrigel$107
- SPACEOAR VUE$106
How this compares
$2,854 in reported general payments places this provider in the 85th percentile of 58 radiation oncology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Betamethasone Dipropionate | 13 | $501 |
| Tamsulosin Hcl | 46 | $306 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $283 |
| SsdSilver Sulfadiazine | 21 | $275 |
| Fluconazole | 16 | $209 |
| Azithromycin | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Shreveport
- Chiachien WangShreveport$31K
- Lane RosenShreveport$10K
- Daniella DangShreveport$2K
- Sanford KatzShreveport$1K
- Michael DurciShreveport$1K
- Russell AndersonShreveport$878
- Federico AmpilShreveport$291
- James RussoLafayette$20K
- Konstantin KovtunBaton Rouge$3K
- James MazeLake Charles$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.